Concepedia

David L. Bilhartz

DL

15

Publications

2.4K

Citations

14

H-Index

1990

Active since

Affiliations

Mayo Clinic(Current)

Urology Associates

Dana-Farber Cancer Institute

Baylor College of Medicine

David L. Bilhartz is an author at Mayo Clinic specializing in medicine, urology, and oncology.

Top concepts

Publications per year

1990–2010

15

Publications

15

Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

Philip W. Kantoff, Thomas Schuetz, Brent A. Blumenstein et al. · Journal of Clinical Oncology · 2010 · 969 citations

Natural History of Rising Serum Prostate-Specific Antigen in Men With Castrate Nonmetastatic Prostate Cancer

Matthew R. Smith, Fairooz F. Kabbinavar, Fred Saad et al. · Journal of Clinical Oncology · 2005 · 493 citations · Full text

Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP.

Charles Y.F. Young, Benjamin T. Montgomery, Paul E. Andrews et al. · PubMed · 1991 · 260 citations

, , +18

Hormonal regulation of prostate‐specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP

Benjamin T. Montgomery, Charles Y.F. Young, David L. Bilhartz et al. · The Prostate · 1992 · 179 citations

Prostate Specific Antigen in Hormonally Treated Stage D2 Prostate Cancer: Is it always an Accurate Indicator of Disease Status?

Mark E. Leo, David L. Bilhartz, Erik J. Bergstralh et al. · The Journal of Urology · 1991 · 121 citations

, , +11

Rows per page

1–5 of 15